
|Articles|December 4, 2004
Cymbalta receives FDA OK for depression maintenance
Duloxetine approved for maintenance of MDD
Advertisement
Eli Lilly & Co. has received regulatory word that antidepressant duloxetine (
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Some Providers Prescribe Unapproved Retatrutide for Weight-Loss at Alarming Rate
2
FDA Approves Bemotrizinol as an OTC Sunscreen Ingredient
3
FDA Approves Lebrikizumab for 8 Week Maintenance of Atopic Dermatitis
4
CDC Will Focus on BA.2.3 COVID-19 Variant for Upcoming Respiratory Season
5





















































